Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis

Medicine and Dentistry

• Amyotrophic Lateral Sclerosis 100%
• Niclosamide 41%
• Fibroblast 25%
• Fibrosis 16%
• Gene 16%
• Calvasculin 16%
• Patient 16%
• Pathology 16%
• Phenotype 8%
• Element 8%
• Diseases 8%
• Cell Type 8%
• Serositis 8%
• Muscle Atrophy 8%
• Small Interfering RNA 8%
• Drug 8%
• Upregulation 8%
• Gliosis 8%
• Chemotherapeutic Agent 8%
• Autophagy 8%
• Muscle Regeneration 8%
• Treatment of Amyotrophic Lateral Sclerosis 8%
• Nerve Tissue 8%
• Comprehension 8%
• Marker 8%
• Spinal Cord 8%
• Organ 8%

Biochemistry, Genetics and Molecular Biology

• S100A4 58%
• Fibroblast 33%
• Nested Gene 16%
• FUS 16%
• Mammalian Target of Rapamycin 16%
• Mouse 16%
• Mutation 8%
• Upregulation 8%
• Phenotype 8%
• Gliosis 8%
• Muscle Regeneration 8%
• Autophagy 8%
• C9orf72 8%
• STAT3 8%
• Comprehension 8%
• Protein 8%
• Small Interfering RNA 8%